Lancashire and South Cumbria
Formulary
Formulary
9 Nutrition and blood
This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents: mlcsu.lscformulary@nhs.net.
For more information about the formulary development process, please see: https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
09-02-01-01 Potassium removal
| Calcium polystyrene sulfonate Calcium Resonium® |
|
Formulary
|
Powder for oral or rectal suspension 99.934% w/w calcium polystyrene sulfonate
|
|
In East Lancashire| Patiromer calcium |
|
Formulary
|
Oral powder sachets 8.4g, 16.8g |
 NICE TA623: Patiromer for treating hyperkalaemia |
|
| Sodium zirconium cyclosilicate |
|
Formulary
|
Oral powder sachets 5g, 10g |
|
NICE TA599: Sodium zirconium cyclosilicate for treating hyperkalaemia |
|
|
Links
- CAS: UPDATE: Discontinuation of Kay-Cee-L (potassium chloride 375mg/ml) (potassium chloride 5mmol/5ml) syrup
LSCMMG: Bariatric surgery guidelines for prescribing of vitamins and nutritional supplements: Position Statement- LSCMMG: Gluten-Free food products: Position Statement
- LSCMMG: Oral Nutritional Supplements in Primary Care
- LSCMMG: PKU - Prescribing of Multivitamins & Phenylalanine-free amino acid substitutes for adults and children
- NICE CG32: Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition
- NICE NG20: Coeliac disease: recognition, assessment and management
- NICE NG203: Chronic kidney disease: assessment and management
- NICE TA599: Sodium zirconium cyclosilicate for treating hyperkalaemia
- NICE TA599: Sodium zirconium cyclosilicate for treating hyperkalaemia
- NICE TA623: Patiromer for treating hyperkalaemia
- NICE TA623: Patiromer for treating hyperkalaemia